BAC
Bank of America Corporation
BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.
TWAV
TaoWeave, Inc.
There isn't enough reported data to score TWAV yet.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
TWAV Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| N/A | |
| N/A |
TWAV's revenue is currently stable, but its profitability is weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like TWAV.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
TWAV PE Valuation
TWAV has no meaningful PE right now: it lost money over the past year.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
TWAV Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong decline | |
| -- | |
| Limited | |
| High |
Analysts expect TWAV's revenue to decline, with its earnings and profitability holding steady.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the stronger earnings trend. Trailing diluted EPS is up 14% for BAC versus TWAV down 101%.
TWAV Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2023 | -$91.78 | +$334.22 |
| Q2 2023 | -$217.78 | +$82.22 |
| Q1 2023 | -$360.58 | -$186.58 |
| Q4 2022 | -$426.58 | -$204.58 |
| Q3 2022 | -$426.00 | -$330.00 |
| Q2 2022 | -$300.00 | +$24.00 |
| Q1 2022 | -$174.00 | +$492.00 |
| Q4 2021 | -$222.00 | +$666.00 |
TWAV lost $2.20 per share over the past year, a smaller loss than the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over TWAV on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over TWAV on profitability, with a higher operating margin.
TWAV Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $522K | -12% |
| Q1 2026 | $707K | +14% |
| Q4 2025 | $622K | +10% |
| Q3 2025 | $601K | +4% |
| Q2 2025 | $592K | -3.1% |
| Q1 2025 | $622K | -0.6% |
| Q4 2024 | $563K | -40% |
| Q3 2024 | $578K | -34% |
TWAV's revenue is growing: $522,000 last quarter, down 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -161% | -46 points |
| Q1 2026 | -79% | +32 points |
| Q4 2025 | -126% | +39 points |
| Q3 2025 | -133% | +52 points |
| Q2 2025 | -115% | +51 points |
| Q1 2025 | -111% | +78 points |
| Q4 2024 | -165% | -30 points |
| Q3 2024 | -185% | -79 points |
TWAV's operating margin was −161% last quarter, down 46 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over TWAV on cash generation, producing positive trailing cash flow while its opponent burns cash.
TWAV Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$539K | -$502K |
| Q1 2026 | -$650K | +$30K |
| Q4 2025 | -$744K | +$141.2K |
| Q3 2025 | -$1.6M | -$643K |
| Q2 2025 | -$37K | +$943K |
| Q1 2025 | -$680K | -$50K |
| Q4 2024 | -$885.2K | -$180.2K |
| Q3 2024 | -$911K | -$805K |
TWAV's free cash flow was −$3M over the past year, against −$3M the year before. Free cash flow isn't a meaningful measure for financial services companies like TWAV.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over TWAV on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
TWAV Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +240% | +2.8M shares |
| 3 years | +7520% | +3.9M shares |
| 5 years | +44564% | +3.9M shares |
| Available history | +45195% | +3.9M shares |
TWAV has 4M diluted shares, up 240% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | $16,000 |
| Q3 2020 | — |
| Q2 2020 | $9,000 |
| Q1 2020 | $7,000 |
| Q4 2019 | — |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
TWAV Net Leverage
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
TWAV Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.9 | Neutral |
| Stochastic | 19.8 | Oversold |
TWAV's weekly RSI is 43 (neutral) and its Stochastic is 20 (oversold).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
TWAV PE vs Financial Services Sector
TWAV has no meaningful PE right now: it lost money over the past year.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has the edge over TWAV on trend strength, trading above more of its moving averages.
TWAV Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.41 | 12% below |
| 20 week MA | $1.35 | 8.1% below |
| 50 week MA | $1.49 | 17% below |
| 100 week MA | $2.39 | 48% below |
| 200 week MA | $14.6 | 92% below |
TWAV is in a downtrend: it's below all five of its weekly moving averages, and 92% below its 200-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over TWAV on returns for 2026, with the stronger performance.
TWAV Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $894.0 | $3,306.0 | +270% |
| 2021 | $3,306.0 | $648.0 | -80% |
| 2022 | $648.0 | $72.0 | -89% |
| 2023 | $72.0 | $8.00 | -89% |
| 2024 | $8.00 | $3.88 | -52% |
| 2025 | $3.88 | $1.97 | -49% |
| 2026 YTD | $1.97 | $1.24 | -37% |
TWAV has finished five years in a row lower, and it's down 37% so far in 2026.